Physician

Steven J Joggerst, MD

According to 2025 Medicare claims, Steven Joggerst, MD (NPI: 1457408262) practices interventional cardiology in the Cape Girardeau, MO-IL market, with the plurality of this provider's patient population coming from Cape Girardeau, MO. This provider's primary affiliated billing organization is SAINT FRANCIS MEDICAL CENTER (NPI: 1578513016; TIN: 237246265) and primary practice location at 63703-8399. Joggerst is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616) and Aledade 238 MO St Francis MSSP (ACO ID: A5556), participating under the MSSP model.

Joggerst's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,092 traditional Medicare patients, billed 2,988 HCPCS/CPT codes, and received $197,428 in Medicare payments. The top billing code was 93458 (Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist). Part D data shows 9,788 prescription claims across 994 beneficiaries totaling $1,366,098 in drug costs, led by Eliquis (Apixaban). DME data shows 44 claims. Open Payments data shows 46 records totaling $2,412. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $44,309 to $1,366,098. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $30,907 and ending at $23,528.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	991	2,698	$177,022
2016	1,207	3,390	$191,617
2017	1,261	3,826	$208,576
2018	1,061	3,138	$203,668
2019	1,149	2,939	$202,373
2020	1,079	2,510	$177,734
2021	1,100	2,484	$191,824
2022	1,111	2,415	$187,488
2023	1,063	2,283	$172,709
2024	1,092	2,988	$197,428

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	152	1,057	$44,309
2016	273	2,559	$82,703
2017	402	3,966	$225,201
2018	573	5,642	$376,320
2019	621	6,388	$439,983
2020	710	7,212	$625,771
2021	790	8,598	$874,310
2022	870	8,820	$1,093,170
2023	942	9,439	$1,357,645
2024	994	9,788	$1,366,098

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$28,806
2016	N/R	13	$26,192
2017	N/R	25	$29,283
2018	N/R	22	$44,343
2019	N/R	49	$29,112
2020	N/R	43	$1,232
2021	N/R	26	$27,889
2022	N/R	N/R	N/R
2023	N/R	44	$2,574
2024	N/R	44	$2,761

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	86	88	$208
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	677	749	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	565	598	$12
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	100	105	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	590	615	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	766	29,423	$572,417
Entresto	Sacubitril/Valsartan	331	12,612	$269,389
Xarelto	Rivaroxaban	262	11,932	$221,846
Jardiance	Empagliflozin	95	4,302	$85,682
Repatha Sureclick	Evolocumab	116	3,248	$62,601

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	25	$1,823
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	19	$938

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$2,412	Edwards Lifesciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steven J. Joggerst, MD?

Tedicare shows public-source Medicare data for Steven J. Joggerst, MD (NPI 1457408262), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven J. Joggerst, MD have ACO affiliation data?

Steven J. Joggerst, MD is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616) and Aledade 238 MO St Francis MSSP (MSSP, ACO ID A5556).

What billing organization is linked to Steven J. Joggerst, MD?

Steven J. Joggerst, MD is linked to SAINT FRANCIS MEDICAL CENTER (billing NPI 1578513016) in the available physician profile data.

Does Steven J. Joggerst, MD have Open Payments data?

Steven J. Joggerst, MD has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.